Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
about
Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.The Application of CRISPR/Cas Technology to Efficiently Model Complex Cancer Genomes in Stem Cells.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.
P2860
Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@ast
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@en
type
label
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@ast
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@en
prefLabel
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@ast
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@en
P2093
P2860
P356
P1433
P1476
Knock out CD44 in reprogrammed ...... and promotes differentiation.
@en
P2093
Haojie Sun
Jinhai Guo
Jinwen Liu
Lejian Lian
Mingzhi Zhang
P2860
P304
44452-44465
P356
10.18632/ONCOTARGET.6090
P407
P577
2015-10-22T00:00:00Z